BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nieuwenhuis B, Haenzi B, Hilton S, Carnicer-Lombarte A, Hobo B, Verhaagen J, Fawcett JW. Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters. Gene Ther 2021;28:56-74. [PMID: 32576975 DOI: 10.1038/s41434-020-0169-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yamauchi K, Okamoto S, Ishida Y, Konno K, Hoshino K, Furuta T, Takahashi M, Koike M, Isa K, Watanabe M, Isa T, Hioki H. Fluorochromized tyramide-glucose oxidase as a multiplex fluorescent tyramide signal amplification system for histochemical analysis. Sci Rep 2022;12:14807. [PMID: 36097273 DOI: 10.1038/s41598-022-19085-9] [Reference Citation Analysis]
2 Rybarikova M, Almacellas Barbanoj A, Schorge S, Déglon N. CNS gene therapy: present developments and emerging trends accelerating industry-academia pathways. Hum Gene Ther 2022. [PMID: 36070435 DOI: 10.1089/hum.2022.177] [Reference Citation Analysis]
3 Jung KM, Park KJ, Kim YM, Han JY. Efficient gene delivery into the embryonic chicken brain using neuron-specific promoters and in ovo electroporation. BMC Biotechnol 2022;22:25. [PMID: 36056347 DOI: 10.1186/s12896-022-00756-4] [Reference Citation Analysis]
4 Gavrish MS, Urazov MD, Mishchenko TA, Turubanova VD, Epifanova EA, Krut’ VG, Babaev AA, Vedunova MV, Mitroshina EV. Overexpression of Brain- and Glial Cell Line-Derived Neurotrophic Factors Is Neuroprotective in an Animal Model of Acute Hypobaric Hypoxia. IJMS 2022;23:9733. [DOI: 10.3390/ijms23179733] [Reference Citation Analysis]
5 Lim CKW, McCallister TX, Saporito-Magriña C, McPheron GD, Krishnan R, Zeballos C MA, Powell JE, Clark LV, Perez-Pinera P, Gaj T. CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes. Mol Ther 2022:S1525-0016(22)00496-8. [PMID: 35965414 DOI: 10.1016/j.ymthe.2022.08.008] [Reference Citation Analysis]
6 Peng Z, Lu H, Yang Q, Xie Q. Astrocyte Reprogramming in Stroke: Opportunities and Challenges. Front Aging Neurosci 2022;14:885707. [DOI: 10.3389/fnagi.2022.885707] [Reference Citation Analysis]
7 Lunev E, Karan A, Egorova T, Bardina M. Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects. Biomedicines 2022;10:1140. [DOI: 10.3390/biomedicines10051140] [Reference Citation Analysis]
8 Kim H, Gao EB, Draper A, Berens NC, Vihma H, Zhang X, Higashi-Howard A, Ritola KD, Simon JM, Kennedy AJ, Philpot BD. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression. Elife 2022;11:e72290. [PMID: 35535852 DOI: 10.7554/eLife.72290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Oyarzabal EA, Hsu LM, Das M, Chao TH, Zhou J, Song S, Zhang W, Smith KG, Sciolino NR, Evsyukova IY, Yuan H, Lee SH, Cui G, Jensen P, Shih YI. Chemogenetic stimulation of tonic locus coeruleus activity strengthens the default mode network. Sci Adv 2022;8:eabm9898. [PMID: 35486721 DOI: 10.1126/sciadv.abm9898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chen HH, Lu HY, Chang CH, Lin SH, Huang CW, Wei PH, Chen YW, Lin YR, Huang HS, Wang PY, Tsao YP, Chen SL. Breast carcinoma-amplified sequence 2 regulates adult neurogenesis via β-catenin. Stem Cell Res Ther 2022;13:160. [PMID: 35410459 DOI: 10.1186/s13287-022-02837-9] [Reference Citation Analysis]
11 Gubinelli F, Cazzolla G, Negrini M, Kulacz I, Mehrdadian A, Tomasello G, Venuti C, Sarauskyte L, Jacobs F, Manfredsson F, Davidsson M, Heuer A. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioural tests. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Morris G, Schorge S. Genetic therapies for neurological disease: state of the art and opportunities for next-generation approaches. Neuroscience 2022:S0306-4522(22)00126-9. [PMID: 35304290 DOI: 10.1016/j.neuroscience.2022.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li Z, Zhang L, Jiang K, Zhang Y, Liu Y, Hu G, Song J. Biosafety assessment of delivery systems for clinical nucleic acid therapeutics. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Au HKE, Isalan M, Mielcarek M. Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings. Front Med (Lausanne) 2021;8:809118. [PMID: 35223884 DOI: 10.3389/fmed.2021.809118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Powell JE, Lim CKW, Krishnan R, McCallister TX, Saporito-Magriña C, Zeballos MA, McPheron GD, Gaj T. Targeted gene silencing in the nervous system with CRISPR-Cas13. Sci Adv 2022;8:eabk2485. [PMID: 35044815 DOI: 10.1126/sciadv.abk2485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
16 Wang J, Lai S, Wang R, Zhou T, Dong N, Zhu L, Chen T, Zhang X, Chen Y. Dopamine D3 Receptor in the Nucleus Accumbens Alleviates Neuroinflammation in a Mouse Model of Depressive-Like Behavior. Brain Behav Immun 2021:S0889-1591(21)00650-4. [PMID: 34971757 DOI: 10.1016/j.bbi.2021.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hersh J, Condor Capcha JM, Iansen Irion C, Lambert G, Noguera M, Singh M, Kaur A, Dikici E, Jiménez JJ, Shehadeh LA, Daunert S, Deo SK. Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery. Pharmaceutics 2021;13:2159. [PMID: 34959441 DOI: 10.3390/pharmaceutics13122159] [Reference Citation Analysis]
18 Marrone L, Marchi PM, Azzouz M. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. Expert Opin Biol Ther 2021. [PMID: 34904932 DOI: 10.1080/14712598.2022.2012148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ito D. Promise of Nucleic Acid Therapeutics for Amyotrophic Lateral Sclerosis. Ann Neurol 2021. [PMID: 34704267 DOI: 10.1002/ana.26259] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Guzman RA, Maruyama M, Moeinzadeh S, Lui E, Zhang N, Storaci HW, Tam K, Huang EE, Utsunomiya T, Rhee C, Gao Q, Yao Z, Yang YP, Goodman SB. The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits. Stem Cell Res Ther 2021;12:503. [PMID: 34526115 DOI: 10.1186/s13287-021-02572-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Haidar M, Viden A, Turner BJ. Advances in Gene Delivery Methods to Label and Modulate Activity of Upper Motor Neurons: Implications for Amyotrophic Lateral Sclerosis. Brain Sci 2021;11:1112. [PMID: 34573134 DOI: 10.3390/brainsci11091112] [Reference Citation Analysis]
22 Stepankova K, Jendelova P, Machova Urdzikova L. Planet of the AAVs: The Spinal Cord Injury Episode. Biomedicines 2021;9:613. [PMID: 34071245 DOI: 10.3390/biomedicines9060613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Patel M, Li Y, Anderson J, Castro-Pedrido S, Skinner R, Lei S, Finkel Z, Rodriguez B, Esteban F, Lee KB, Lyu YL, Cai L. Gsx1 promotes locomotor functional recovery after spinal cord injury. Mol Ther 2021;29:2469-82. [PMID: 33895323 DOI: 10.1016/j.ymthe.2021.04.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Cappella M, Elouej S, Biferi MG. The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders. Front Cell Dev Biol 2021;9:662837. [PMID: 33937264 DOI: 10.3389/fcell.2021.662837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fuller-Carter PI, Basiri H, Harvey AR, Carvalho LS. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration. BioDrugs 2020;34:763-81. [PMID: 33136237 DOI: 10.1007/s40259-020-00453-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
26 Bi X, Beck C, Gong Y. Genetically Encoded Fluorescent Indicators for Imaging Brain Chemistry. Biosensors (Basel) 2021;11:116. [PMID: 33920418 DOI: 10.3390/bios11040116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Park KW, Wood CA, Li J, Taylor BC, Oh S, Young NL, Jankowsky JL. Gene therapy using Aβ variants for amyloid reduction. Mol Ther 2021;29:2294-307. [PMID: 33647457 DOI: 10.1016/j.ymthe.2021.02.026] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Rietz A, Hodgetts KJ, Lusic H, Quist KM, Osman EY, Lorson CL, Androphy EJ. Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy. Life Sci Alliance 2021;4:e202000889. [PMID: 33234679 DOI: 10.26508/lsa.202000889] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Andrews MR. Gene therapy in the CNS-one size does not fit all. Gene Ther 2021;28:393-5. [PMID: 32978509 DOI: 10.1038/s41434-020-00196-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]